About NyquistAI
NyquistAI is a company based in Palo Alto (United States) founded in 2020 by Michelle Wu and Qiang Kou. NyquistAI has raised $6 million across 1 funding round from investors including Lightspeed Venture Partners, Peterson Ventures and GSR Ventures. NyquistAI offers products and services including Nyquist Pharma, Nyquist MedTech, Nyquist IQ, Nyquist Scholar, and Custom Solutions. NyquistAI operates in a competitive market with competitors including Komodo Health, Clarify, Elucidata, Panalgo and IDBS, among others.
- Headquarter Palo Alto, United States
- Founders Michelle Wu, Qiang Kou
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Nyquist Data, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$6 M (USD)
in 1 rounds
-
Latest Funding Round
$6 M (USD), Seed
Mar 23, 2022
-
Investors
Lightspeed Venture Partners
& 2 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of NyquistAI
NyquistAI offers a comprehensive portfolio of products and services, including Nyquist Pharma, Nyquist MedTech, Nyquist IQ, Nyquist Scholar, and Custom Solutions.
Platform for clinical pipeline and therapy data analysis
Tool for global clinical and regulatory device data
Automates data analysis and insight generation from reports
Streamlines literature reviews and paper recommendations
Integrates AI for organizational efficiency and workflows
Funding Insights of NyquistAI
NyquistAI has successfully raised a total of $6M through 1 strategic funding round. The most recent funding activity was a Seed round of $6 million completed in March 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in NyquistAI
NyquistAI has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Lightspeed Venture Partners, Peterson Ventures and GSR Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Seed-stage venture capital investments are provided by Peterson Ventures.
|
Locked | Locked | Locked | |
|
Venture capital investing in innovative companies across global sectors is undertaken by Lightspeed Venture Partners.
|
Locked | Locked | Locked | |
|
Early-stage tech startups are invested in by GSR Ventures.
|
Locked | Locked | Locked |
Investor details for NyquistAI
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by NyquistAI
Investment portfolio details for NyquistAI
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - NyquistAI
Detailed financials for NyquistAI
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Nyquistai Comparisons
Peer comparison for NyquistAI
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of NyquistAI
NyquistAI operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Komodo Health, Clarify, Elucidata, Panalgo and IDBS, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Data-driven insights are delivered to healthcare via AI platforms.
|
|
| Locked | Locked | Locked |
Marketing and business consulting services are provided by Clarify.
|
|
| Locked | Locked | Locked |
Elucidata is focused on AI-powered biomedical data solutions for drug discovery and precision medicine.
|
|
| Locked | Locked | Locked |
Provider of healthcare analytics software for clinics
|
|
| Locked | Locked | Locked |
Data management is provided for research teams' screening experiments.
|
|
| Locked | Locked | Locked |
GenAI-powered analytics software is provided for biopharma secondary research.
|
Detailed competitors of NyquistAI
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Nyquistai
Complete news archive for NyquistAI
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about NyquistAI
NyquistAI was founded in 2020 and raised its 1st funding round 2 years after it was founded.
NyquistAI is headquartered in Palo Alto, United States. It is registered at Palo Alto, California, United States.
Michelle Wu is the current CEO of NyquistAI. They have also founded this company.
NyquistAI is a funded company, having raised a total of $6M across 1 funding round to date.
NyquistAI was founded in 2020 and is based in Palo Alto, United States. A cloud-based AI platform is provided for the life sciences sector, focusing on clinical and regulatory intelligence. Access to data aggregation, workflow automation, and predictive analytics for medical devices is enabled through this platform, supporting researchers in the industry.
NyquistAI's top competitors include Komodo Health, Elucidata and Panalgo.
NyquistAI offers Nyquist Pharma, Nyquist MedTech, Nyquist IQ, Nyquist Scholar, and Custom Solutions.
NyquistAI has 3 investors. Key investors include Lightspeed Venture Partners, Peterson Ventures, and GSR Ventures.